NCT07834333

Brief Summary

This single-center, single-blind, randomized, sham-controlled clinical trial will include 60 patients aged \>45 years who are within 3 months of a first-ever middle cerebral artery ischemic stroke. Participants will be randomized into four groups: coupled TBS (contralesional cTBS followed by ipsilesional iTBS), cTBS plus sham iTBS, sham cTBS plus iTBS, or sham TBS. TBS will be delivered over the primary motor cortex for 10 sessions over 2 weeks. Stimulation intensity will be set at 80% of the resting motor threshold determined using EMG-guided motor evoked potentials. Each cTBS and iTBS application will consist of 600 pulses. All participants will additionally receive standardized conventional rehabilitation for at least 4 weeks. The primary outcome will be upper-extremity motor recovery assessed using the motor domain of the Fugl-Meyer Assessment. Secondary outcomes will include lower-extremity motor recovery, spasticity, sensory function, cortical excitability, functional ambulation, activities of daily living, and stroke-specific quality of life. Assessments will be performed at baseline, after the 2-week intervention, and at 1-month post-treatment follow-up.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
12mo left

Started Sep 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
Sep 2026Sep 2027

First Submitted

Initial submission to the registry

August 28, 2026

Completed
25 days until next milestone

First Posted

Study publicly available on registry

September 22, 2026

Completed
8 days until next milestone

Study Start

First participant enrolled

September 30, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2027

Last Updated

September 22, 2026

Status Verified

August 1, 2026

Enrollment Period

11 months

First QC Date

August 28, 2026

Last Update Submit

September 18, 2026

Conditions

Keywords

Theta Burst StimulationStroke RehabilitationMotor RecoveryUpper Extremity Motor FunctionLower Extremity Motor FunctionCortical ExcitabilityTranscranial Magnetic Stimulation

Outcome Measures

Primary Outcomes (3)

  • Change in Upper Extremity Motor Function Assessed by the Fugl-Meyer Assessment - Upper Extremity Motor Subscale (FMA-UE)

    Upper extremity motor function will be assessed using the motor subsection of the Fugl-Meyer Assessment. The FMA-UE motor score ranges from 0 to 66, with higher scores indicating better upper extremity motor function. Each item is scored on a 3-point ordinal scale: 0 = cannot perform, 1 = performs partially, and 2 = performs fully

    Baseline, Week 2, and Week 6

  • Change in Lower Extremity Motor Function Assessed by the Fugl-Meyer Assessment - Lower Extremity Motor Subscale

    Lower extremity motor recovery will be assessed using the lower extremity motor subsection of the Fugl-Meyer Assessment.

    Baseline, Week 2, and Week 6

  • Change in Motor Recovery Stage Assessed by the Brunnstrom Motor Recovery Stages

    Motor recovery of the upper and lower extremities will be evaluated using the Brunnstrom Motor Recovery Stages. Each assessed region is rated separately from stage I (1) to stage VI (6), with higher stages indicating better motor recovery.

    Baseline, Week 2, and Week 6

Secondary Outcomes (7)

  • Change in Spasticity Assessed by the Modified Ashworth Scale

    Baseline, Week 2, and Week 6

  • Change in Sensory Function Assessed by the Fugl-Meyer Assessment - Sensory Subscale

    Baseline, Week 2, and Week 6

  • Change in Cortical Excitability Assessed by Motor Evoked Potential Amplitude

    Baseline, Week 2, and Week 6

  • Change in Cortical Excitability Assessed by Motor Evoked Potential Latency

    Baseline, Week 2, and Week 6

  • Change in Functional Ambulation Assessed by the Functional Ambulation Scale

    Baseline, Week 2, and Week 6

  • +2 more secondary outcomes

Study Arms (4)

Coupled TBS Group

EXPERIMENTAL

Participants will receive contralesional continuous theta burst stimulation (cTBS) followed by ipsilesional intermittent theta burst stimulation (iTBS) within the same session. Ten sessions will be administered over 2 weeks in addition to standardized conventional rehabilitation.

Device: Continuous Theta Burst Stimulation (cTBS)Device: Intermittent Theta Burst Stimulation (iTBS)

cTBS + Sham iTBS Group

EXPERIMENTAL

Participants will receive contralesional continuous theta burst stimulation (cTBS) followed by ipsilesional sham intermittent theta burst stimulation (sham iTBS) within the same session. Ten sessions will be administered over 2 weeks in addition to standardized conventional rehabilitation.

Device: Continuous Theta Burst Stimulation (cTBS)Device: Sham Intermittent Theta Burst Stimulation

Sham cTBS + iTBS Group

EXPERIMENTAL

Participants will receive contralesional sham continuous theta burst stimulation (sham cTBS) followed by ipsilesional intermittent theta burst stimulation (iTBS) within the same session. Ten sessions will be administered over 2 weeks in addition to standardized conventional rehabilitation.

Device: Intermittent Theta Burst Stimulation (iTBS)Device: Sham Continuous Theta Burst Stimulation

Sham TBS Group

SHAM COMPARATOR

Participants will receive contralesional sham continuous theta burst stimulation (sham cTBS) followed by ipsilesional sham intermittent theta burst stimulation (sham iTBS) within the same session. Ten sessions will be administered over 2 weeks in addition to standardized conventional rehabilitation.

Device: Sham Continuous Theta Burst StimulationDevice: Sham Intermittent Theta Burst Stimulation

Interventions

Continuous theta burst stimulation will be applied over the contralesional primary motor cortex (M1) at 80% of the resting motor threshold. A total of 600 pulses will be delivered over 40 seconds as triplets at 50 Hz repeated every 200 ms.

Coupled TBS GroupcTBS + Sham iTBS Group

Intermittent theta burst stimulation will be applied over the ipsilesional primary motor cortex (M1) at 80% of the resting motor threshold. A total of 600 pulses will be delivered over approximately 190 seconds using 2-second trains repeated every 10 seconds.

Coupled TBS GroupSham cTBS + iTBS Group

Sham continuous theta burst stimulation will be delivered over the contralesional primary motor cortex using a sham coil for 40 seconds.

Sham TBS GroupSham cTBS + iTBS Group

Sham intermittent theta burst stimulation will be delivered over the ipsilesional primary motor cortex using a sham coil for approximately 190 seconds.

Sham TBS GroupcTBS + Sham iTBS Group

Eligibility Criteria

Age45 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of ischemic stroke due to middle cerebral artery (MCA) occlusion confirmed by magnetic resonance imaging (MRI).
  • Within the first 3 months after stroke.
  • First-ever stroke.
  • Age ≥45 years.
  • Brunnstrom stage 1, 2, or 3 for the upper extremity and hand.
  • No previous physical therapy after the current stroke.
  • Ability to maintain at least minimal semi-sitting balance.
  • Medically and neurologically stable.
  • Mini-Mental State Examination score \>24.
  • Native Turkish speaker who voluntarily agrees to participate and provides written informed consent.

You may not qualify if:

  • History of epilepsy.
  • Presence of a pacemaker.
  • Pregnancy.
  • Neurological disease other than stroke.
  • Metallic implants in the brain or scalp, including cochlear implants.
  • History of brain surgery.
  • Comorbid disease that may significantly impair general health, such as heart f-failure or chronic obstructive pulmonary disease, and/or severe infection.
  • Diagnosis of malignancy.
  • Peripheral nerve injury and/or musculoskeletal disorder affecting motor function of the upper or lower extremities, such as fracture.
  • Cardiac arrhythmia.
  • Aphasia, spatial neglect, or visual field loss.
  • Visual or hearing impairment that prevents communication.
  • Alcohol and/or drug dependence.
  • Refusal to participate or failure to provide informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Etlik Şehir Hastanesi

Ankara, Yenimahalle, 06170, Turkey (Türkiye)

RECRUITING

Related Publications (5)

  • Long H, Wang H, Zhao C, Duan Q, Feng F, Hui N, Mao L, Liu H, Mou X, Yuan H. Effects of combining high- and low-frequency repetitive transcranial magnetic stimulation on upper limb hemiparesis in the early phase of stroke. Restor Neurol Neurosci. 2018;36(1):21-30. doi: 10.3233/RNN-170733.

    PMID: 29439359BACKGROUND
  • Kuzu O, Adiguzel E, Kesikburun S, Yasar E, Yilmaz B. The Effect of Sham Controlled Continuous Theta Burst Stimulation and Low Frequency Repetitive Transcranial Magnetic Stimulation on Upper Extremity Spasticity and Functional Recovery in Chronic Ischemic Stroke Patients. J Stroke Cerebrovasc Dis. 2021 Jul;30(7):105795. doi: 10.1016/j.jstrokecerebrovasdis.2021.105795. Epub 2021 Apr 20.

    PMID: 33887662BACKGROUND
  • Chen Q, Shen D, Sun H, Ke J, Wang H, Pan S, Liu H, Wang D, Su M, Fang Q. Effects of coupling inhibitory and facilitatory repetitive transcranial magnetic stimulation on motor recovery in patients following acute cerebral infarction. NeuroRehabilitation. 2021;48(1):83-96. doi: 10.3233/NRE-201606.

    PMID: 33361618BACKGROUND
  • Fu Y, Wang C, Zhang L, Ji D, Xiang A, Qi J, Zhao R, Wu L, Jin S, Zhang Q. The effectiveness of theta burst stimulation for motor recovery after stroke: a systematic review. Eur J Med Res. 2024 Nov 29;29(1):568. doi: 10.1186/s40001-024-02170-2.

    PMID: 39609900BACKGROUND
  • Meng Y, Zhang D, Hai H, Zhao YY, Ma YW. Efficacy of coupling intermittent theta-burst stimulation and 1 Hz repetitive transcranial magnetic stimulation to enhance upper limb motor recovery in subacute stroke patients: A randomized controlled trial. Restor Neurol Neurosci. 2020;38(1):109-118. doi: 10.3233/RNN-190953.

    PMID: 32039879BACKGROUND

MeSH Terms

Conditions

Ischemic Stroke

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

Fatma Melis Ertuğrul Öztürk, Resident

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Participants and the TMS operator administering the stimulation will be blinded to group allocation. Sham stimulation will be delivered using a sham coil designed to mimic the corresponding active TBS procedures, thereby maintaining blinding of both participants and the TMS operator throughout the intervention.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
pm&r specialist

Study Record Dates

First Submitted

August 28, 2026

First Posted

September 22, 2026

Study Start

September 30, 2026

Primary Completion (Estimated)

August 30, 2027

Study Completion (Estimated)

September 30, 2027

Last Updated

September 22, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Locations